Dr. RR Baliga's 'Podkast for the Kurious Doc'

Dr. RR Baliga's 'Podkast for the Kurious Doc'

A large nationwide cohort study in JAMA compared amoxicillin-clavulanate vs amoxicillin for acute sinusitis in >500,000 adults. Treatment failure was low (~3%) with no significant difference between groups (RR 0.96). However, broader-spectrum therapy increased secondary infections, including yeast and C. difficile.   The message is clear: narrow-spectrum amoxicillin remains a rational first-line choice for uncomplicated sinusitis—balancing efficacy, safety, and stewardship.   Sometimes, the quiet drug wins the loud debate.

Dr. RR Baliga's 'Podkast for the Kurious Doc'

A quiet revolution in medicine began not in a laboratory—but in a dialogue. 🌿   Punarvasu Atreya, one of the earliest architects of Ayurveda, transformed healing into a disciplined science through teaching, inquiry, and debate. His legacy—preserved in the Charaka Samhita and Bhela Samhita—shaped centuries of clinical reasoning and holistic care.   From Takshashila to modern medicine, his influence endures: listen deeply, question rigorously, heal compassionately. 🩺   A reminder that the best physicians are not just healers—but teachers of wisdom. ✨

Dr. RR Baliga's 'Podkast for the Kurious Doc'

A thoughtful, practice-shaping study in NEJM explores a long-standing clinical dilemma: can we truly move the needle in post-thrombotic syndrome?   The C-TRACT trial shows that endovascular therapy (iliac-vein stenting) significantly improves symptom burden and quality of life in patients with moderate–severe disease—measured rigorously using VCSS, VEINES-QOL, and SF-36. The magnitude of benefit is clinically meaningful.   But every intervention casts a shadow.   👉 Bleeding risk was ~3-fold higher, largely driven by intensified antithrombotic therapy. 👉 Durability...

Dr. RR Baliga's 'Podkast for the Kurious Doc'

A landmark study in the New England Journal of Medicine shows that hypertension control is no longer just about prescribing medications—it’s about systems, teams, and sustained engagement. 🩺📊   In a cluster-randomized trial across underserved populations, a multifaceted, team-based strategy—combining protocol-driven care, health coaching, and home BP monitoring—achieved a significant additional reduction of −6.4 mm Hg in systolic BP (P<0.001) and improved adherence.   The message is clear: 👉 Evidence works—but only when implemented well 👉 Teams outperform...

Dr. RR Baliga's 'Podkast for the Kurious Doc'

Sex hormones shape cardiovascular risk in subtle yet powerful ways. From estrogen-driven changes in coagulation to formulation-specific differences in VTE risk, the nuance matters. Transdermal estradiol offers a safer path, while ethinyl estradiol reminds us that dose and route are destiny. The key is not avoidance—but precision: matching therapy to individual risk.   Three takeaways: • Formulation matters • First year matters • Patient factors matter   #Cardiology #Thrombosis #PrecisionMedicine #HormoneTherapy

Dr. RR Baliga's 'Podkast for the Kurious Doc'

  A landmark study on transcatheter tricuspid valve replacement (TTVR) offers compelling real-world evidence 🫀   ✅ 98.4% procedural success ✅ Near-complete TR elimination (97.7% at 30 days) ✅ Significant improvement in symptoms & quality of life ⚠️ Trade-off: ~16% new pacemaker rate in device-naïve patients   In an elderly, high-risk cohort, TTVR delivers what surgery often cannot—restoration without incision, relief without delay.   A meaningful step forward in structural heart disease—where the right heart finally takes center stage ✨

Dr. RR Baliga's 'Podkast for the Kurious Doc'

  A quiet shift, yet a profound one. 🧠   The OCEANIC-STROKE trial introduces asundexian, a Factor XIa inhibitor that lowers recurrent ischemic stroke risk (HR 0.74) without increasing major bleeding—a long-sought balance in antithrombotic therapy.   For decades, we traded efficacy for safety. Now, we may finally have both. ⚖️   The implications extend beyond stroke—to a broader rethinking of thrombosis itself: can we uncouple clot from bleed?   This study suggests we can.   #StrokePrevention #Cardiology #Neurology #ClinicalTrials #Anticoagulation...

Dr. RR Baliga's 'Podkast for the Kurious Doc'

  🧠 Brain metastases remain a clinical frontier—common, complex, and still lethal. In Science Signaling, Chafe et al. unpack the biology: Blood Brain Barrier traversal, metabolic rewiring, and immune evasion.   Key insight: metastasis is not just spread—it is adaptation.   From adenosine-driven immunosuppression to neuronal-like tumor states, new therapeutic doors are opening.   Precision oncology must now think beyond the primary tumor.   #BrainMetastases #Oncology #NeuroOncology #Immunotherapy #PrecisionMedicine

Dr. RR Baliga's 'Podkast for the Kurious Doc'

What if the roots of modern surgery were written over 2,000 years ago? 🩺📜   Meet —a pioneer whose Suśruta Saṃhitā laid the foundations of plastic surgery, cataract procedures, and structured medical training. From rhinoplasty to hands-on simulation using natural models, his approach was remarkably ahead of its time.   A reminder that innovation is often rediscovery—and that the future of medicine is deeply anchored in its past. 🌍✨   #HistoryOfMedicine #Ayurveda #Surgery #MedicalEducation #Innovation

Dr. RR Baliga's 'Podkast for the Kurious Doc'

  🧠💊 Stop. Test. Rethink.   A compelling new study in JAMA shows that ~26% of adults ≥60 years can safely discontinue levothyroxine, maintaining normal thyroid function—especially those on low doses (≤50 μg/day).   📉 No meaningful decline in quality of life 📊 Clear dose-response signal ⚠️ Raises concerns about lifelong overtreatment   The message is elegant: Not every prescription deserves permanence.   Time to reassess, deprescribe, and individualize—particularly in our older patients.   #Thyroid #Endocrinology #Deprescribing #Geriatrics...